Among the characteristic gene generated from the model, loss of VIPR1 expression in HCC facilitated CAD phosphorylation and tumor progression, suggesting that the restoration of VIPR1 and treatment with the VIPR1 agonist may represent a promising approach for HCC treatment (32, 36). This evidence concerns the gene VIPR1 and neoplasm.